Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

153 ta ish

Ish: Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives

  1. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository

    Kenneth Clark, Bruce A. Vendt, Kirk Smith +9

    Maqola20138 iqtibos
    ABI

  2. Principles of early drug discovery

    J. P. HUGHES, S. Rees, S. Barret Kalindjian +1

    Sharh maqola20106 iqtibos
    ABI

  3. Machine Learning in Medicine

    Alvin Rajkomar, Jay B. Dean, Isaac S. Kohane

    Sharh maqola20195 iqtibos
    ABI

  4. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

    Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai +18

    Maqola20173 iqtibos
    ABI

  5. CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions

    Wanghong Hu, Zhenguo Zi, Yanling Jin +5

    Maqola20183 iqtibos
    ABI

  6. Artificial intelligence in radiology

    Ahmed Hosny, Chintan Parmar, John Quackenbush +2

    Sharh maqola20183 iqtibos
    ABI

  7. Artificial intelligence in cancer imaging: Clinical challenges and applications

    Wenya Linda Bi, Ahmed Hosny, Matthew B. Schabath +16

    Sharh maqola20193 iqtibos
    ABI

  8. Study on artificial intelligence: The state of the art and future prospects

    Caiming Zhang, Yang Lu

    Maqola20213 iqtibos
    ABI

  9. Artificial intelligence assists precision medicine in cancer treatment

    Jinzhuang Liao, Xiaoying Li, Yu Gan +5

    Sharh maqola20233 iqtibos
    ABI

  10. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

    Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles +28

    Maqola20163 iqtibos
    ABI

  11. Radiomics: the bridge between medical imaging and personalized medicine

    Philippe Lambin, Ralph T. H. Leijenaar, Timo M. Deist +17

    Sharh maqola20173 iqtibos
    ABI

  12. Development and validation of three machine-learning models for predicting multiple organ failure in moderately severe and severe acute pancreatitis

    Qiu Qiu, Yongjian Nian, Yan Guo +6

    Maqola20193 iqtibos
    ABI

  13. International evaluation of an AI system for breast cancer screening

    Scott Mayer McKinney, Marcin Sieniek, Varun Godbole +28

    Maqola20203 iqtibos
    ABI

  14. Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?

    Reid F. Thompson, Gilmer Valdés, Clifton D. Fuller +10

    Sharh maqola20182 iqtibos
    ABI

  15. Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer

    Amanda Rosewell Shaw, Caroline E. Porter, Norihiro Watanabe +5

    Maqola20172 iqtibos
    ABI

  16. CAR T cells in solid tumors: challenges and opportunities

    Faroogh Marofi, Roza Motavalli, В. А. Сафонов +12

    Sharh maqola20212 iqtibos
    ABI

  17. Artificial Intelligence in Cancer Research: Trends, Challenges and Future Directions

    Anu Maria Sebastian, David Peter

    Sharh maqola20222 iqtibos
    ABI

  18. Protecting Your Patients’ Interests in the Era of Big Data, Artificial Intelligence, and Predictive Analytics

    Patricia Balthazar, Peter A. Harri, Adam Prater +1

    Maqola20182 iqtibos
    ABI

  19. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

    Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González +30

    Maqola20172 iqtibos
    ABI

  20. Radiomics: Extracting more information from medical images using advanced feature analysis

    Philippe Lambin, Emmanuel Rios-Velazquez, Ralph T. H. Leijenaar +8

    Sharh maqola20122 iqtibos
    ABI

  21. In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

    Sean P. Arlauckas, Christopher Garris, Rainer H. Köhler +9

    Maqola20172 iqtibos
    ABI

  22. From machine learning to deep learning: progress in machine intelligence for rational drug discovery

    Lu Zhang, Jianjun Tan, Dan Han +1

    Sharh maqola20172 iqtibos
    ABI

  23. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

    Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel +26

    Maqola20182 iqtibos
    ABI

  24. Next generation of immune checkpoint therapy in cancer: new developments and challenges

    Julian A. Marin‐Acevedo, Bhagirathbhai Dholaria, Aixa Soyano +3

    Sharh maqola20182 iqtibos
    ABI

  25. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors

    Satya Das, Douglas B. Johnson

    Sharh maqola20192 iqtibos
    ABI